Stark David Matthew
Insider CIK 1722360 · ASRT Director · TEVA Exec. VP Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ASRT Assertio Holdings, Inc. | D To issuer deriv | 2026-06-16 | 2026-06-16 | 5,415 | — | $0 | 0 | SEC↗ |
| ASRT Assertio Holdings, Inc. | D To issuer deriv | 2026-06-16 | 2026-06-16 | 5,415 | — | $0 | 0 | SEC↗ |
| ASRT Assertio Holdings, Inc. | U Tender | 2026-06-16 | 2026-06-16 | 11,420 | — | $0 | 0 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award | 2026-05-05 | 2026-05-06 | 4,851 | — | $0 | 11,420 | SEC↗ |
| ASRT Assertio Holdings, Inc. | S Sale | 2025-11-10 | 2025-11-12 | 8,959 | $0.76 | $6.8K | 98,541 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award deriv | 2025-05-07 | 2025-05-09 | 81,225 | — | $0 | 81,225 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award | 2025-05-07 | 2025-05-09 | 53,750 | — | $0 | 107,500 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award deriv | 2024-11-07 | 2024-11-12 | 81,225 | — | $0 | 81,225 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award | 2024-11-07 | 2024-11-12 | 53,750 | — | $0 | 53,750 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2023-03-07 | 2023-03-08 | 49,475 | $9.43 | $466.5K | 2,974 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2023-03-06 | 2023-03-08 | 16,491 | $9.93 | $163.8K | 52,449 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-03-05 | 2023-03-07 | 20,199 | — | $0 | 40,400 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-03-05 | 2023-03-07 | 20,199 | — | $0 | 68,940 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-03-04 | 2023-03-07 | 31,836 | — | $0 | 95,509 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-03-04 | 2023-03-07 | 13,931 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-03-04 | 2023-03-07 | 31,836 | — | $0 | 48,741 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-03-04 | 2023-03-07 | 13,931 | — | $0 | 16,905 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2023-03-03 | 2023-03-07 | 94,621 | — | $0 | 94,621 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-02-28 | 2023-03-02 | 44,953 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-02-28 | 2023-03-02 | 18,430 | — | $0 | 18,430 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2023-02-28 | 2023-03-02 | 18,430 | $9.89 | $182.3K | 2,974 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2023-02-28 | 2023-03-02 | 44,953 | $9.89 | $444.6K | 2,974 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-02-28 | 2023-03-02 | 44,953 | — | $0 | 47,927 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-02-28 | 2023-03-02 | 18,430 | — | $0 | 21,404 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2023-02-07 | 2023-02-09 | 44,953 | — | $0 | 44,953 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-07-28 | 2022-07-29 | 58,163 | $9.04 | $525.8K | 2,974 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-03-07 | 2022-03-08 | 9,057 | $7.37 | $66.8K | 61,137 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-03-05 | 2022-03-08 | 20,199 | — | $0 | 60,599 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-03-05 | 2022-03-08 | 20,199 | — | $0 | 70,194 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-03-04 | 2022-03-08 | 13,930 | — | $0 | 13,931 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2022-03-04 | 2022-03-08 | 127,345 | — | $0 | 127,345 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-03-04 | 2022-03-08 | 37,939 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-03-04 | 2022-03-08 | 37,939 | — | $0 | 59,319 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-03-04 | 2022-03-08 | 17,008 | $7.48 | $127.2K | 42,311 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-03-04 | 2022-03-08 | 13,930 | — | $0 | 56,241 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-03-04 | 2022-03-08 | 6,246 | $7.48 | $46.7K | 49,995 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-02-28 | 2022-03-02 | 18,430 | — | $0 | 36,860 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-02-28 | 2022-03-02 | 6,452 | $8.14 | $52.5K | 21,380 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-02-28 | 2022-03-02 | 18,430 | — | $0 | 27,832 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-02-09 | 2022-02-10 | 12,538 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-02-09 | 2022-02-10 | 12,538 | — | $0 | 15,512 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-02-09 | 2022-02-10 | 6,110 | $9.06 | $55.4K | 9,402 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2022-02-08 | 2022-02-10 | 37,939 | — | $0 | 37,939 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-05-11 | 2021-05-13 | 37,884 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-05-11 | 2021-05-13 | 37,884 | $10.22 | $387.2K | 2,974 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-05-11 | 2021-05-13 | 37,884 | — | $0 | 40,858 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2021-03-05 | 2021-03-08 | 80,798 | — | $0 | 80,798 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-03-04 | 2021-03-08 | 13,930 | — | $0 | 27,861 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-03-04 | 2021-03-08 | 13,930 | $10.57 | $147.2K | 2,974 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-03-04 | 2021-03-08 | 13,930 | — | $0 | 16,904 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-03-01 | 2021-03-02 | 18,430 | $10.83 | $199.6K | 2,974 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-02-28 | 2021-03-02 | 18,430 | — | $0 | 55,290 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-02-28 | 2021-03-02 | 18,430 | — | $0 | 21,404 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-02-16 | 2021-02-17 | 3,926 | $11.12 | $43.7K | 2,974 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-02-14 | 2021-02-17 | 3,926 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-02-14 | 2021-02-17 | 3,926 | — | $0 | 6,900 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-02-09 | 2021-02-11 | 12,538 | — | $0 | 12,538 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2021-02-09 | 2021-02-11 | 37,884 | — | $0 | 37,884 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-02-09 | 2021-02-11 | 12,538 | — | $0 | 15,512 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award | 2021-02-09 | 2021-02-11 | 52,774 | — | $0 | 68,286 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-02-09 | 2021-02-11 | 12,538 | $12.69 | $159.1K | 55,748 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-02-09 | 2021-02-11 | 52,774 | $12.69 | $669.7K | 2,974 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-03-17 | 2020-03-19 | 2,359 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-03-17 | 2020-03-19 | 2,359 | $7.16 | $16.9K | 2,974 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-03-17 | 2020-03-19 | 2,359 | — | $0 | 5,333 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2020-02-28 | 2020-03-03 | 73,720 | — | $0 | 73,720 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-02-14 | 2020-02-18 | 3,926 | — | $0 | 3,926 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-02-14 | 2020-02-18 | 13,090 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-02-14 | 2020-02-18 | 13,090 | — | $0 | 16,064 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-02-14 | 2020-02-18 | 3,926 | — | $0 | 19,990 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-02-14 | 2020-02-18 | 13,090 | $12.14 | $158.9K | 6,900 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-02-14 | 2020-02-18 | 3,926 | $12.14 | $47.7K | 2,974 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2020-02-11 | 2020-02-13 | 13,090 | — | $0 | 13,090 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-02-10 | 2020-02-11 | 12,538 | $12.24 | $153.5K | 2,974 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-02-09 | 2020-02-11 | 12,538 | — | $0 | 25,076 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-02-09 | 2020-02-11 | 12,538 | — | $0 | 15,512 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-03-18 | 2019-03-19 | 2,358 | $16.43 | $38.7K | 2,974 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-03-17 | 2019-03-19 | 2,358 | — | $0 | 2,359 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-03-17 | 2019-03-19 | 2,358 | — | $0 | 5,332 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-03-12 | 2019-03-14 | 2,444 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-03-12 | 2019-03-14 | 2,444 | $15.82 | $38.7K | 2,974 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-03-12 | 2019-03-14 | 2,444 | — | $0 | 5,418 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2019-03-04 | 2019-03-06 | 41,791 | — | $0 | 41,791 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-02-14 | 2019-02-19 | 3,926 | — | $0 | 7,852 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-02-14 | 2019-02-19 | 3,926 | $17.74 | $69.6K | 2,974 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-02-14 | 2019-02-19 | 3,926 | — | $0 | 6,900 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2018-03-19 | 2018-03-20 | 2,358 | $18.38 | $43.3K | 2,974 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-03-17 | 2018-03-20 | 2,358 | — | $0 | 4,717 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-03-17 | 2018-03-20 | 2,358 | — | $0 | 5,332 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-03-12 | 2018-03-14 | 2,441 | — | $0 | 2,444 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2018-03-12 | 2018-03-14 | 2,441 | $19.20 | $46.9K | 2,974 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-03-12 | 2018-03-14 | 2,441 | — | $0 | 5,415 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2018-02-09 | 2018-02-12 | 37,614 | — | $0 | 37,614 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2018-02-09 | 2018-02-12 | 95,890 | — | $0 | 95,890 | SEC↗ |